Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Eagle Veterinary Tech Co., Ltd. (044960:KRX), powered by AI.
Eagle Veterinary Tech Co., Ltd. is currently trading at ₩3,150. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Eagle Veterinary Tech Co., Ltd. on Alpha Lenz.
Eagle Veterinary Tech Co., Ltd.'s P/E ratio is 10.1.
“Eagle Veterinary Tech Co., Ltd. trades at a P/E of 10.1 (undervalued) with modest ROE of 7.9%.”
Ask for details →Eagle Veterinary Tech Co., Ltd. is a company primarily dedicated to enhancing the health and welfare of animals through its veterinary products and solutions. The company focuses on the development, manufacturing, and distribution of pharmaceuticals, nutraceuticals, and various health care products specifically designed for the veterinary industry. Its offerings are integral in supporting veterinarians, farms, and pet owners in ensuring optimal animal care and well-being. This company's products are essential in the livestock industry, aiding in the prevention and treatment of various animal diseases and conditions. Also, it plays a crucial role in the companion animal sector, where the health and maintenance of pets are of significant economic and emotional value. Eagle Veterinary Tech Co., Ltd. has positioned itself as a key player in the veterinary pharmaceutical market, contributing to advancements in animal health through research, development, and innovation. The company's operations not only support agricultural efficiency and productivity but also ensure that pets and livestock receive top-tier health management, highlighting its importance in both the economic and emotional landscapes of the broader market.
“Eagle Veterinary Tech Co., Ltd. trades at a P/E of 10.1 (undervalued) with modest ROE of 7.9%.”
Ask for details →Eagle Veterinary Tech Co., Ltd. (ticker: 044960) is a company listed on KRX in the Common Stock sector (Common Stock). Market cap is $39.8B.
The current price is ₩3,150 with a P/E ratio of 10.09x and P/B of 0.77x.
ROE is 7.85% and operating margin is 10.06%. Annual revenue is $43.3B.